VOLUME 30 NUMBER 9 SEPTEMBER 2012 nature biotechnology l e t t e r s Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which regulates chloride and water transport across all epithelia and affects multiple organs, including the lungs. Here we report an in vitro directed differentiation protocol for generating functional CFTRexpressing airway epithelia from human embryonic stem cells. Carefully timed treatment by exogenous growth factors that mimic endoderm developmental pathways in vivo followed by air-liquid interface culture results in maturation of patches of tight junction-coupled differentiated airway epithelial cells that demonstrate active CFTR transport function. As a proof of concept, treatment of CF patient induced pluripotent stem cell-derived epithelial cells with a small-molecule compound to correct for the common CF processing mutation resulted in enhanced plasma membrane localization of mature CFTR protein. Our study provides a method for generating patientspecific airway epithelial cells for disease modeling and in vitro drug testing.
l e t t e r s Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which regulates chloride and water transport across all epithelia and affects multiple organs, including the lungs. Here we report an in vitro directed differentiation protocol for generating functional CFTRexpressing airway epithelia from human embryonic stem cells. Carefully timed treatment by exogenous growth factors that mimic endoderm developmental pathways in vivo followed by air-liquid interface culture results in maturation of patches of tight junction-coupled differentiated airway epithelial cells that demonstrate active CFTR transport function. As a proof of concept, treatment of CF patient induced pluripotent stem cell-derived epithelial cells with a small-molecule compound to correct for the common CF processing mutation resulted in enhanced plasma membrane localization of mature CFTR protein. Our study provides a method for generating patientspecific airway epithelial cells for disease modeling and in vitro drug testing.
Efforts to differentiate human embryonic stem cells (hESCs) into lung epithelia have generated cells that express distal airway epithelial phenotypes expressing surfactant protein-C 1-3 . These reports relied on spontaneous mixed-lineage embryoid bodies to differentiate hESCs directly into lung endoderm with low efficiency and generated mostly cells expressing distal alveolar markers. A recent study showed a stepwise generation of lung endoderm progenitors from human induced pluripotent stem cells (iPSCs) but failed to generate mature proximal and distal lung epithelial phenotypes 4 . To date, no studies have been able to generate proximal conducting airway epithelia with functional polarized CFTR. Therefore, we developed a method to recapitulate the sequential processes that progressively restrict progenitor cells from endoderm to proximal lineage-specific lung epithelia 5, 6 and were able to generate functional proximal conducting airway epithelia expressing CFTR from human pluripotent stem cells.
Because lung forms from definitive endoderm, we first differentiated hESCs toward definitive endoderm using a previously described method 7 , based on developmental pathways of endoderm formation at gastrulation 6 . Treatment with activin-A and WNT3A for 4 d was sufficient to induce a large percentage of cells into definitive endoderm as determined by co-expression of CXCR4 and cKIT, and the endoderm transcription factors FOXA2 and SOX17 (Supplementary Fig. 1) .
After gastrulation, anterior-posterior signals pattern the primitive gut tube into distinct regions 6 . The developing cardiac mesoderm patterns the anterior ventral foregut endoderm through secretion of fibroblast growth factor-2 (FGF2) 8 . High concentration of FGF2 induces an NKX2.1 expression domain typical of the early lung endoderm 9 . Sonic hedgehog (SHH) signaling promotes embryonic lung growth and suppresses pancreatic development 10, 11 . Thus, to promote anterior foregut identity and specify lung cell fate, definitive endoderm cells were treated with FGF2 and SHH ( Supplementary Fig. 2 ). After 5 d of exposure, 85% of the cells expressed the pan-endoderm transcription factor FOXA2. The majority (78%) of the cells coexpressed the pan-epithelial marker EpCAM and the transcription factor NKX2.1. Upregulation of genes associated with anterior foregut endoderm transcription factors-SOX2 and NKX2.1-as well as pharyngeal endoderm FOXG and thyroid TG and PAX9 was observed by means of RT-PCR. The posterior hindgut gene CDX2 was not detected. NKX2.1 is a good marker for lung endoderm but is also expressed in the thyroid and forebrain 12 . Although other thyroid genes were seen, notably, the ectoderm PAX6 was also not detected, which excludes the possibility of forebrain-derived NKX2.1 expression. The definitive endoderm gene SOX17 was downregulated, but some expression of transcription factors indicative of liver (HNF4) and pancreas (NKX6.1 and PDX) was detected, suggesting that other endoderm lineages were also present. Nonetheless, FGF2 and SHH can efficiently induce anterior foregut derivatives from definitive endoderm.
Gain-and loss-of-function studies in mouse embryonic lung organ cultures combined with studies in null and transgenic mouse lines Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFtr protein l e t t e r s have identified specific growth factors important for lung development from the NKX2.1-expressing endoderm 5 , including FGF and BMP4. FGF10 is a key growth factor expressed by the mesenchyme at the earliest stage of lung development and stimulates lung bud outgrowth and organogenesis 13 . FGF7, also expressed by the mesenchyme, is mainly involved in stimulating fluid secretion in the lungs but has a role in epithelial cell growth 14 . We found that the combination of FGF7 and FGF10 at 50 ng/ml augmented mRNA expression of the transcription factor genes NKX2.1 and FOXA2 compared to definitive endoderm levels ( Supplementary Fig. 3 ). As the lung bud actively branches, the bud stalk (future conducting airways) matures in an environment where signals that drive bud tip outgrowth are reduced or repressed 15 . High concentrations of BMP4 stimulate a distal cell fate whereas low concentrations promote a proximal cell fate 16 . Retinoic acid signaling upregulates FGF10 in the developing lung mesenchyme to stimulate lung bud outgrowth 17 but it also plays a key role in inducing alveolar epithelial cell fate and surfactant production during the later phase of lung development 18 . Therefore, to enhance proximal airway fate and suppress distal cell fate, we incubated cultures with varying levels of BMP4 and in the absence of retinoic acid. The hESC-derived anterior foregut cells were exposed to FGF10, FGF7 and varying concentrations of BMP4 to determine the optimal concentration of BMP4 that would induce proximal cell fate ( Fig. 1a,b) . RT-PCR showed that low concentrations of BMP4 induced upregulated gene expression of airway cell genes such as KRT5 and TRP63 (also known as TP63; P63, basal cell), FOXJ1 and SOX17 (glial cell), NKX2.1, CFTR and pan-endoderm marker FOXA2 (Fig. 1c) . Another airway marker, MUC5AC (goblet cell marker), was not detected. In addition, the distal type II alveolar cell marker SFTPC (encoding surfactant protein-C) and Clara cell secretory marker SCGB1A1 (more abundant in the smaller conducting airways) were not detected. SOX9, a distal tip marker found in the developing lung bud, was also detected. Therefore, a combination of FGF7, FGF10 and low concentrations of BMP4 can induce upregulation of some conducting airway cell lineages from anterior foregut endoderm.
To further promote airway differentiation, we added FGF18, which enhances proximal but not distal airway formation and plays a role in increasing the size of the conducting airways following maturation of the epithelium 19 (Fig. 2a,b ). This resulted in further upregulation of airway genes KRT5, TRP63, FOXJ1, SOX17, MUC5AC and CFTR, lower levels of SCGB1A1 and little detection of SFTPC ( Fig. 2c) . NKX2.1 and FOXA2 and the distal tip progenitor SOX9 were downregulated. Relative to their adult tissue counterparts, other endoderm lineage markers-AFP (liver), PDX1, TG and PAX9 (pharyngeal endoderm)-were not detected at this stage. Moreover, flow cytometric quantification revealed cells that expressed pancytokeratin (panKRT, 33%) CFTR (30%), FOXJ1 (36%) and NKX2.1 (32%) ( Fig. 2d ), suggesting that at least one-third of the cells in the culture were of the ciliated CFTR-expressing airway phenotype. Over 50% of the cells were P63 + , suggesting that the vast majority of the cells were potentially basal cell progenitors, previously shown to give rise to other proximal airway lineages 20 . Significant cell proliferation, as measured by BrdU incorporation, occurred during the first 14 d of differentiation and declined by the late proximal specification stage (D19, Fig. 2e,f) . The increased expression of proximal lineage markers on day 19 is consistent with the reduction in cell proliferation as differentiation progressed. Collectively, our data support a mechanism for airway development in which FGF7, FGF10, BMP4 and FGF18 are required to promote airway lineage development.
Notably, this method of directed differentiation was broadly applicable to several pluripotent cell lines with varying efficiencies npg l e t t e r s ( Supplementary Fig. 4 ). During the early stages of differentiation, upregulated expression of the early lung marker NKX2.1 was variable between the hESC lines. Similarly, differentiation of several wildtype iPSC and CF iPSC lines also showed varying efficiencies in lung marker expression ( Supplementary Fig. 5 ). This suggests that optimization of the differentiation protocol may be required to reflect line-to-line variability.
To further develop and mature the cells toward functional airway epithelium in vitro, we employed commercially available media that support the growth and differentiation of primary bronchial epithelial cells ex vivo along with air-liquid interface (ALI) growth condition to mimic the post-natal airway epithelial niche in vivo and promote differentiation, maturation and polarization of the epithelium (Fig. 3a) . To achieve ALI, the cells were exposed to air on the apical side of a transwell membrane while the basolateral side was exposed to media. After 5 weeks of ALI, flow cytometry revealed that at least 50% of the CFTR + cells coexpressed panKRT, FOXJ1 and LHS28 (basal bodies of cilia), indicating an enrichment of cells typical of the ciliated epithelium ( Fig. 3b) . A greatly reduced percentage (5%) of cells expressing P63
(an airway progenitor cell marker 20 ) was observed ( Supplementary  Fig. 6 ), suggesting that the putative P63 + basal progenitor cells may have differentiated into other airway epithelial lineages, as has been previously shown 21 . In addition, the majority of the cells expressed other conducting airway epithelia markers: acetylated tubulin TUBA1A (cilia), MUC1 (Goblet cell), KRT14 (basal epithelia) and the pan-endoderm marker FOXA2. A smaller percentage (15%) of cells expressed the transcription factor NKX2.1, which in later stages of lung development regulates Clara cell and type II alveolar cell differentiation 22 . No cells positive for the pancreatic ductal epithelia marker HPD1 were found, excluding the possibility that pancreatic ductal epithelial cells were the source of CFTR. Proximal airway epithelium was established as indicated by protein expression of mucin 16 (a marker of the tracheal epithelium 23 ) and cytokeratin 16 (ref. 24) ( Supplementary Fig. 7) . Gene expression analysis by real-time RT-PCR showed upregulation of proximal airway lineage genes (SOX17, FOXJ1, MUC5AC, TRP63, KRT5, ARG2, SOX2, CFTR, KRT16, MUC16, NGFR) comparable or higher than levels in total adult lung or tracheal tissue (Fig. 3c) . Clara cell marker SCGB1A1 npg l e t t e r s and alveolar epithelial cell SFTPC, PDPN, P2X7 and the transcription factor genes NKX2.1, FOXA2, FOXA1 and SOX9 were only observed at very low levels (Supplementary Fig. 8 ). Low levels of the thyroid TG and PAX9, liver HNF4 and AFP, and pancreas PDX1 genes were also detected ( Supplementary Fig. 9 ), suggesting that the maturation of the lung lineages remained heterogeneous with other endoderm lineages also present. With the exception of PITX3, the other esophageal markers DLX3 and MUC2 were not detected. The stratified epithelial marker mainly expressed in the skin, KRT15, was also detected. However, no gene expression of the neuronal lineage PAX6 and the forebrain gene FOXG1 was observed. Immunofluorescence staining and confocal analysis of 5-week-old ALI cultures showed contiguous patches of epithelial cells typified by membrane expression of Zona Occludin-1 (ZO1), a protein associated with tight junctions, and co-staining with pan-KRT ( Fig. 3d) and CFTR (Fig. 3e) . Reconstructed confocal stacked images showed apical plasma membrane localization of CFTR (green) (Fig. 3f) . Stained sections of the cultures showed ciliated cells (Fig. 3g, H&E) , confirmed with antibody staining for cilia (beta IV tubulin, green) and apically localized CFTR (orange) ( Fig. 3h high, Fig. 3i low magnification, respectively). In addition, the cultures stained positive for MUC5AC on the surface of the cells, indicative of mucin production (Fig. 3j) . These findings suggest air-liquid interface can induce maturation and polarization of a ciliated large airway epithelium with proper localization of the CFTR protein.
Directed differentiation of CF mutant iPSCs into airway epithelial cells holds great promise for disease modeling and drug discovery. The most common CF mutation (~70% of cases 25 ) is caused by a phenylalanine deletion at position 508 (F508del). We generated CF-iPSC lines from three F508del subjects by reprogramming primary human fibroblasts using retroviruses containing the four pluripotency factors (OCT4, KLF4, C-MYC and SOX2) as previously described 26 . Genotype analysis was performed to confirm that the reprogrammed cells carried the F508del homozygous mutation ( Supplementary  Fig. 10) . CF-iPSC lines expressed pluripotency markers TRA1-81, TRA1-60 and NANOG, highly expressed endogenous pluripotency genes OCT4, SOX2, KLF4 and C-MYC, and did not express the reprogramming retroviral transgenes, a hallmark of pluripotent stem cells (Supplementary Fig. 11) . In vitro embryoid body formation and in vivo teratoma assays revealed that the lines generate cell types of all three germ layers (Supplementary Fig. 12a) . Expression of the other pluripotency markers TERC and TERT and genes associated with full reprogramming DNMT3B and REX1 were detected ( Supplementary  Fig. 12b ). Therefore CF-iPSCs generated by retroviral-mediated reprogramming characteristically resembles hESCs and are functionally pluripotent.
To sample the functional expression of CFTR in patches of epithelium, we used a modification of the iodide efflux 27 npg l e t t e r s plasma membrane-localized functional protein, was detectable by western blot analysis in hESC-derived, but not in CF-iPSC-derived, cultures (Fig. 4a) . We then tested whether the in vitro differentiated epithelium from normal hESCs and CF-iPSCs ( Supplementary  Fig. 13 ) possessed cyclic AMP-regulated CFTR anion channel activity using a halide efflux assay. As expected from similar studies in epithelial cells endogenously expressing CFTR in their apical membranes, such as Caco-2 cells, a human colorectal adenocarcinoma epithelial cell line, cAMP agonists stimulated peak iodide efflux within 1-2 min in differentiated cultures (Fig. 4b) . There was heterogeneity with respect to the functional expression of CFTR in different cell lines, with two of the four hESC lines exhibiting cAMP-activated efflux. Of these two hESC cell lines, one exhibited robust responses (Fig. 4c ) similar to levels of control Caco-2 cells and the other, modest responses (green symbols). There was heterogeneity with respect to the efficacy of the differentiation protocol, with two of four differentiation trials leading to responsive cultures in the first cell line and three of six in the second cell line. The reasons for this variability have yet to be fully defined but likely reflect different proportions of polarized CFTR-expressing epithelial cells in each culture. Nonetheless, this stepwise, directed differentiation overcomes the previously encountered barriers to generating mature functional CFTR-expressing proximal airway epithelia.
In the F508del CF mutation, the mutant CFTR protein does not fold properly in the endoplasmic reticulum, preventing it from being properly trafficked to the plasma membrane. Instead, the mutant protein is rapidly targeted for degradation 28 . Recent studies have shown that small molecules called 'corrector' compounds are effective in partially rescuing the trafficking defect of the major mutant 29 . As a proof of concept experiment to determine whether CF-iPSC-derived epithelial cells may be used to evaluate CF corrector compounds, we tested the effect of C18, an active analog of the small molecule VX-809 (currently in phase 2 clinical trials), in promoting plasma membrane localization of F508del-CFTR in CF-iPSC-derived epithelial cells (Fig. 4d) . Notably, no surface-localized F508del-CFTR was detected in control DMSO-treated CF-iPSC cultures, but cultures treated for 24 h with C18 (10 µM) exhibited patches of cells expressing CFTR on their cell surface. Although we could not observe substantial changes in cAMP-regulated iodide efflux from C18-treated cells (data not shown), we did observe a trend toward a change in the Band C to Band B ratio of F508del-CFTR protein in C18-treated cultures versus DMSO-treated cultures from one F508del-CFTR proband (Fig. 4e,f) . Overall, CF-iPSC-derived airway cells may provide a renewable source of patient-specific cells to identify new or validate existing CF therapeutic drugs.
To our knowledge there has been no previous report demonstrating that human pluripotent stem cells can be directed to differentiate in vitro into CFTR-functional conducting airway epithelium. Although the differentiation protocol generates heterogeneous endoderm lineages, a great majority of the cells express airway epithelia markers, with establishment of CFTR function observed in a third of the cultures. Further refinement by isolating the cells using positive and negative selection or cell-surface marker identification of lung progenitor populations would improve the purity of lung epithelial cells. This study also serves as a proof of concept that CF-iPSC-derived epithelial cells may be used to validate existing, or identify new, therapeutic modulators of CFTR activity. This can be done in a patientspecific manner, taking into account the genetic modifiers 30 that underlie the heterogeneity in F508del CF pathologies. Patient-specific iPSC-derived airway epithelial cells hold future promise of regenerative medicine approaches to treat serious lung diseases.
MeTHOdS
Methods and any associated references are available in the online version of the paper.
Immunoblotting. Cells were solubilized in 1% sodium dodecyl sulfate (SDS) and sample protein run on 6% SDS gels for SDS-PAGE. Protein samples were transferred to nitrocellulose paper. Primary CFTR antibody (MAB1660 (R&D) or antibody #450 courtesy of J.R. Riordan) and goat anti-mouse Ig HRP secondary antibody were used for immunoblotting. Immunoblot was exposed to enhanced chemiluminescence (ECL).
Proliferation assay. BrdU incorporation was assessed by flow cytometry using the BD BrdU flow kit (catalog # 552598) and performed using manufacturer's protocol. Cells were incubated with BrdU for 24 h before analysis.
Statistical analysis. Unless otherwise specified, for statistical analysis, unpaired t-tests were performed. When more than two groups were compared, one-way ANOVA was used followed by Dunnett's post-test if significance was observed. Results were expressed as mean ± s.e.m. 
